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Population dynamics P system modelA new bioinspired computational model was developed for the SARS-CoV-2 pandemic using the available epide-
miological information, high-resolution population density data, travel patterns, and the average number of con-
tacts between people. The effectiveness of control measures such as contact reduction measures, closure of
communities (lockdown), protective measures (social distancing, face mask wearing, and hand hygiene), and
vaccinationweremodelled to examine possibilities for control of the disease under several protective vaccination
levels in the population. Lockdown and contact reductionmeasures only delay the spread of the virus in the pop-
ulation because it resumes its previous dynamics as soon as the restrictions are lifted. Nevertheless, these mea-
sures are probably useful to avoid hospitals being overwhelmed in the short term. Our model predicted that
56% of the Spanish population would have been infected and subsequently recovered over a 130 day period if
no protective measures were taken but this percentage would have been only 34% if protective measures had
been put in place. Moreover, this percentage would have been further reduced to 41.7, 27.7, and 13.3% if 25,
50 and 75% of the population had been vaccinated, respectively. Finally, this percentage would have been even
lower at 25.5, 12.1 and 7.9% if 25, 50 and 75% of the population had been vaccinated in combination with the ap-
plication of protective measures, respectively. Therefore, a combination of protective measures and vaccination
would be highly efficacious in decreasing not only the number of those who become infected and subsequentlyce, ETSEA, University of Lleida, 25198 Lleida, Spain.
.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
M.ªÀ. Colomer, A. Margalida, F. Alòs et al. Science of the Total Environment 789 (2021) 147816recover, but also the number of people who die from infection, which falls from 0.41% of the population over a
130 day period without protective measures to 0.15, 0.08 and 0.06% if 25, 50 and 75% of the population had
been vaccinated in combination with protective measures at the same time, respectively.
© 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A new coronavirus (SARS-CoV-2) spread quickly in China at the end
of 2019, and then rapidly in other areas. The first case of SARS-CoV-2
was reported on 1 December 2019 in the city of Wuhan (China) and
the initial outbreak was connected to the Huanan seafood market
(Zhang et al., 2020;Mizumoto et al., 2020). This new coronavirus causes
a disease named Covid-19 with clinical signs that vary widely between
patients, from an asymptomatic infection to severe disease requiring
critical care in hospital. Many different symptoms associated with this
disease have been described and vary on a patient-to-patient basis.
The most common symptoms are cough, fever, shortness of breath or
difficulty breathing, fatigue, muscle or body aches, headache, loss of
taste or smell, sore throat, and diarrhea (Kui et al., 2020; Casas-Rojo
et al., 2020). As a result, a percentage of patients finally die as a conse-
quence of the disease. Mortality varies according to country and other
factors such as patient age, ethnicity, underlying disease comorbidities,
and the measures taken to treat the disease (https://ourworldindata.
org/mortality-risk-covid#the-current-case-fatality-rate-of-covid-19).
Europe become a new centre of the outbreak of this new virus dur-
ing spring 2020, but it became distributed worldwide within a very
short period of time from December 2019 to March 2020 (Spiteri
et al., 2020; Li et al., 2020). As a consequence of this rapid spread, the
World Health Organization (WHO) declared Covid-19 to be a global
pandemic. Afterwards, on 17March 2020, the European Union adopted
a decision unprecedented in its history and closed all its external bor-
ders in an attempt to mitigate the spread of this global pandemic.
During the first wave of disease, most countries only had the capac-
ity to test a small proportion of suspected cases and diagnostic tests
were reserved for severely ill patients or high-risk groups (e.g. those
who had had contacts with confirmed cases). A 2–3 week period be-
tween infection and the outcome became established in the literature
(Lei et al., 2020; Qin et al., 2020). The available data therefore gave a sys-
tematically biased view of trends in the pandemic's spread. For this rea-
son, the recorded death records were more informative because they
are registered in a more robust way in many countries, although the
time lag between the outcomes of treatment and the registration of
deaths should be taken into account.
Different research teams have studied the epidemiological parame-
ters of SARS-CoV-2 (Byrne et al., 2020) although many are subject to
continuous updates due to the short period of time since the outbreak
began (Nishiura, 2007). These parameters are an essential tool in
deciphering the most suitable preventive measures to control this dis-
ease. Mathematical models can provide new insights into the epidemi-
ology of infectious diseases and suggest criteria for more efficient
control strategies. Such models are tools for understanding key points
in epidemiology such as disease transmission and dynamics, revealing
the implications of the spread of pathogens. Model outcomes for ‘what
if’ scenarios can be used to predict the effects of future interventions.
However, most of themodels developed so far have low predictive per-
formances because of the uncertainty of some of the epidemiological
parameters on which they are based (Huang et al., 2020; Press and
Levin, 2020). Thus, ordinary differential equations (ODE), partial deriv-
ative equations, real-time estimation of mortality caused by COVID-19
using patient information base algorithm have been used to model the
dynamics of SARS-CoV-2 outbreak (Wang et al., 2020). On the other
hand, Population Dynamic P system (PDP)models (inspired by the biol-
ogy of cell function) provide other approach of modelling that have
never been applied in human epidemiology until now (Colomer et al.,2
2021). Briefly, cells can perform multiple processes simultaneously
and in a synchronized fashion, which makes them suitable for the
modelling of complex problems. New emerging generations of compu-
tational models such as PDP models are useful tools for the study of
complex problemswith very large numbers of interactions in amore ef-
ficient way and have been successfully applied in ecology (Margalida
et al., 2011; Colomer et al., 2013) and veterinary medicine (Colomer
et al., 2019, 2020). These agent-based models do not require a high
workload from a computational point of view and can be run on an ev-
eryday laptop.
A PDP agent-based stochastic model was developed to decipher the
course of the SARS-CoV-2 pandemic under several different epidemio-
logical scenarios. Our first goal was to set up a simulation model,
based on PDP model criteria, for any new disease in a naïve population
using high-resolution population density data, data on human travel
patterns, and average contact frequencies between people. The model
was validated using the Spanish outbreak data before and after contact
control measures such as social distancing and lockdowns. The second
goal was to decipher the effects of a vaccination program with several
levels of vaccine efficacy and coverage in the population using the pre-
viously developed model.
2. Materials and methods
2.1. Ethical statement
Not necessary because modelling exercises do not involve any ex-
periments, either with animal or human subjects.
2.2. SARS-CoV-2 modelling using a PDP model
PDP models (Păun et al., 2010) are computational models inspired
by cell functioning whereby small organelles grow, evolve, reproduce,
and die, while interacting with their surroundings and other organelles
of the same or different types. Cells evolve in a random way and PDP
models emulate their functions through rules of evolution that turn
them into stochastic models. The components of a PDP model
(Colomer et al., 2013) include: 1) the number of environments; 2) the
membrane structure of the cell contained in each environment; 3) the
objects in the initial configuration; and 4) the rules of evolution
(Fig. 1). Cell membranes have a hierarchical organization, and the
outer membrane (skin membrane) may contain more membranes
within. To differentiate them, they are labeled with a subscript, the
state of themembrane being indicated by a superscript which indicates
its electric charge (either+,−, or 0). The objects associatedwith the in-
dividuals in the population reside in the spaces delimited by the
membranes. Thus, in our model the object S indicates an individual sus-
ceptible to infection, I indicates an infected individual, while R indicates
a recovered individual (Fig. 1). The rules of evolution are written in the
form of a chemical reaction (Fig. 1): if a healthy individual (S) is in con-
tact with an infected one (I), it can become infectedwith a probability p.
If an infected individual is outside membrane 1 and this membrane also
has a positive charge, it can recover with probability r.
Themodelmimics the functioning of a society in a simplifiedway, so
the study area must be divided into differentiated physical units. In the
case of Spain, where there are 19 administrative communities, it would
be divided into 19 areas where the density of population is assumed to
be the same for each region but different across them. In each area, the











Fig. 1. Components of a PDP model for modelling SARS-CoV-2.
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were defined as 0–2 (nursery), 3–5 (preschool), 5–11 (primary educa-
tion), 12–17 (secondary education), 18–25 (university education),
26–60 (working period) and >60 years old (elderly/retired from
work). The retired period was divided into three additional sub-
periods (61–70, 71–80 and >80 years old) due to the different lethality
of the disease observed during the elderly period. Each age group has its
own behavior and daily routines, which will determine the average
number of people with whom members of the group interact on a
daily basis, as well as its movement characteristics between geographi-
cal areas. It is assumed that each person inside the same age group has a
similar behavior. Thus, the number of contacts is an average value inside
each age group. Thus, it was expected that a 10-year-old childwasmore
likely to transmit the virus to children of similar ages than to adults,
whereas an older person tends to interact more with older people. In
general, a person is more likely to transmit the virus to another person
of a similar age group (Fig. 2).
The model defines the average number of people in each age group
with a close relationship to people of any other age group. Note that, it is
not known how the virus was introduced into the population and that
the model makes it possible to choose the number of initial virus foci
(index cases) and to place them in a deterministic or random way
among the geographical areas that have been established. Because it is
not knownhow the viruswasfirst introduced, the fociwere initially dis-
tributed at random in all of the simulations. In summary, the model
used epidemiological and demographic parameters (Table 1) for simu-
lation (Guan et al., 2020; Lauer et al., 2020; He et al., 2020; Holshue
et al., 2020; Chen et al., 2020; Hellewell et al., 2020; Anderson et al.,
2020; Bi et al., 2020; Liu et al., 2020a, 2020b; Ferguson et al., 2020). In
the case of SARS-CoV-2, the published epidemiological characteristics
of the virus were used in the execution of the model (Table 1) in
order to predict the dynamics of the virus spread. Remarkably, in this
model the reproduction rate was not included as a key parameter to
launch the model and the probability of virus transmission from in-
fected people to uninfected ones was only introduced into the model
as a variable to find out which value better fitted the predicted out-
comes when compared with the real data reported from the Spanish
outbreak. Asymptomatic and symptomatic individuals can both trans-
mit the disease, and the contagious period can bemodified by the inves-
tigator according to updated information regarding the disease as new
information comes to light. It was assumed that if an individual was
symptomatic, the disease was detected and, consequently, the person
was required to self-isolate so as not to infect more people. In the
model, it is assumed that the persons respect strictly this recommenda-
tion. The values introduced into the model for each parameter were
means± standard deviations. Therefore, themodel randomly generates
values for incubation time, contagiousness, and the time taken to3
recover for each infected individual. Once an individual had recovered
from the disease, it was assumed that they were immunized for a vari-
able time t, measured in days. If people did not manifest the disease,
theywent onwith normal life, implying that theywere free tomove be-
tween communities. The model estimates a probability of travel be-
tween or inside each community and also estimates an average
duration of each trip, measured in days.
PDPs are agent-based models in which each individual moves
around acting according to their own specific rules and is included in
larger groups (e.g. communities), in order to better mimic the
dynamics of human populations. In our case the number of individuals
was 46million (the population of Spain), grouped into 19 communities.
The unit ofwork timewas oneday. Themodel outputswere the number
of people in the chosen community, day, and age group that were:
asymptomatic; symptomatic; newly infected each day; recovered after
infection; and died after infection. Asymptomatic people travelling to
other communities and those who were infected during the trip were
registered, grouping them by community, day, and age group. All this
information is available on a daily basis on the simulation but we have
decided to show data in a simpler way. Thus, we have showed the
data as dead persons and recovered ones that are the infected ones
that have overcome the disease on a daily basis. The model allows the
investigator to quantify the movement restrictions necessary to control
the pandemic because they can be set up as parameters in the model
according to the investigator's requirements. Moreover, the model
also allows the investigator to set the percentage compliance with the
measures at the individual level in the various age ranges. Finally, the
model also allows study of the effect of vaccinating a set percentage of
the populationwith a vaccine of a given efficacy. The vaccine is assumed
to be administered randomly in the population without taking into
account different age groups. The detailed evolutionary rules of the
model are provided in the Supplementary information (see Appendix
A).
2.3. SARS-CoV-2 outbreak modelling with and without control measures
PDP models were used to assess the effect of different control mea-
sures to mitigate the SARS-CoV-2 pandemic. We simulated the effec-
tiveness of control measures (contact reduction measures, closure of
communities (lockdown) and protective measures) and vaccination in
controlling the disease under different protective vaccination levels
(i.e. efficacy level combined with population coverage). This analysis
was performed in three Phases:
2.3.1. Phase 1
The first experiments were performed to estimate the probability of
disease transmission, validated against real data from the Spanish
Fig. 2. Flow of SARS-CoV-2 in the population, taking into account the status (infected or non-infected), the development of symptoms (asymptomatic or symptomatic), the location in any
geopraphical community, and the necessity for hospitalization of individuals.
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were performed using a probability of transmission in the range
0.05–0.5. The dynamics of the disease were simulated over a 90 day pe-
riod with 30 repetitions of each scenario.
Modelling SARS-CoV-2 is complex and depends on various parame-
ters. The sensitivity of the model can be studied with respect to each
parameter but here we focus on only several epidemiological
parameters pertinent to the objectives of this study, and held the
remainder of the parameters constant in the model runs (Table 1).
The sensitivity of the PDP SARS-CoV-2 model was studied using a Box-
Behnken design with three factors, each at two levels: the contagious
period (7 and 15 days); the number of foci at the beginning of the
outbreak (1 and 15); and the probability of transmitting the virus
from an infected to a non-infected person (p = 0.05 and 0.15). Sixteen
scenarios were therefore modelled.4
Two response surfaces were estimated, one for each of the re-
sponse variables studied: the numbers of people who died and who
recovered following infection (the total number of people infected
is the sum of those recovering and dying). These surfaces allowed
us to assess the sensitivity of the PDP model to small variations in
the factors involved.
2.3.2. Phase 2
Contact reduction measures, closure of communities (lock-
down), and protective measures (including facing mask wearing,
social distancing, and hand hygiene) were studied as pandemic con-
trol measures. The first two factors were studied at two levels: Yes/
No. Contact reduction measures can be applied at different levels
(defined in Table 1 as the r parameter). In this Phase, contact reduc-
tion measures mean complete removal of contacts between age
M.ªÀ. Colomer, A. Margalida, F. Alòs et al. Science of the Total Environment 789 (2021) 147816groups, with the exception of individuals between 18 and 70-years-
old, where the reduced contact taken to be 80% with a 90% compli-
ance. In addition, the simulations of contact reduction measures
began 21 days after the beginning of the outbreak and ended on
day 63, and the closure of communities (lockdown) ran from day
20 to day 48 following the beginning of the outbreak. Protective
measures are designed to decrease the probability of virus transmis-
sion from infected to non-infected people. The starting point was a
transmission probability of 10% and this value could be reduced de-
pending on the measures applied and the degree of compliance. The
range of values studied therefore went from 1% to 10%.
Our study showed that control measures significantly affect the
outcomes of the model: the numbers of people dying and recover-
ing. The factors studied and the levels used are shown in Table 2.
The remainder of the parameters used in the model are shown in
Table 1.Table 1
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The effect of protecting part of the population by applying protective
measures and mass vaccination was modelled over a 130 day period.
The probability of disease transmission without and with protective
measures was set at 10% (initially validated in Phase 1 of the study)
and 5%, respectively. The percentage of the population protected by vac-
cinationwas set as either 0 (no vaccination), 25, 50 and 75%, taking into
account the combination of vaccine efficacy and population coverage
(see Section 2.4 below). A total of 30 repetitions of the eight scenarios
were performed in these experiments.
2.4. Data analysis
All statistical analyses were performed using the R Core package (R
Core, 2020, https://www.R-project.org/). The EpiEstim package was
used to calculate the reproduction rate taking into account the outcomeSARS-CoV-2 PDP model.
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throughout a pandemic using the analysis of time series of incidence
as described in Cori et al. (2013) and Wallinga and Teunis (2004).
Box-Bhenken designs were performed to find out the sensitivity of
the model using the DoEbase package in the R software package. Two
response surfaces were obtained, one for each dependent variable,
and these were used to estimate the sensitivity of the model. In Phase
1 of the study, a relative mistake was calculated from the difference be-
tween the values obtained by the model and the actual values, as pub-
lished by the Spanish Ministry of Health, according to formula (1). The
probability of transmission of the disease that generates the minimum
relative mistake was chosen as the most suitable one to set up the
model, assuming that the virus circulates freely in the population with-
out control measures.
Relative Mistake ¼ Model value−Governmental value
Governmental value
 100 ð1Þ
The results obtained in Phase 2 and Phase 3 were analyzed using a
generalized linear model (GLM), with a link identity function and aTable 2
Levels of the factors under study.
Factor Levels
Contact reduction measures Yes/no
Closure of communities (lockdown) Yes/no
Probability of transmitting the disease from an infected to an
uninfected person applying different protective measures
[0.01 − 0.1]
6
Gaussian distribution. For Phase 2, the independent variables were con-
tact reduction measures, closure of communities (lockdown) and pro-
tective measures. For Phase 3 of the study, the independent variables
were the percentage of the population protected by vaccination, calcu-
lated as the percentage of people vaccinated (coverage) multiplied by
the efficacy of the vaccine, and the application of social measures. The
response variables in all of the Phases correspond to the numbers of
people dying and recovering after infection with SARS-CoV-2. The ef-




Model validation was performed taking into account the official
death toll values as a key parameter due to its robustness. Where the
probability of transmission is 0.05 or 0.15, the model underestimates
and overestimates the official data, respectively, assuming free circula-
tion of the virus in the population, the differences being always negative
or positive, respectively (Table 3). Where p = 0.1, the differences be-
tween the values estimated by the model and the official data can be
positive or negative and the mean relative error was the smallest of
the three values of probability tested, suggesting that a probability of
disease transmission of around 0.10 was probably closest to reality
(Table 3). Therefore, it appears that the outcomes generated when the
p value= 0.10 are very close (Fig. 3) to the actual underlying reproduc-
tion ratio (Rt) observed during the outbreak, as published by the
Spanish Department of Health (90-day series from 25 February to
24 May) (Fig. 3).
Table 3
Results of the validation tests of the PDP SARS-CoV-2 model showing the range of values
(minimum and maximum), how many differences were positive or negative, the mean
value of the errors, and the mean value of the absolute value of the errors.
Probability of transmitting the disease from an infected to
an uninfected person assuming free circulation of the
virus in the population
0.05 0.1 0.15
Minimum relative error −0.99 −0.81 0.00
Maximum relative error −0.57 0.25 2.19
Negative relative errors 74 25 0
Positive relative errors 0 49 73
Mean relative error −0.86 −0.10 0.94
Mean absolute relative error 0.86 0.25 0.94
Table 4
Results of the Box-Behnken model to study the sensitivity of the PDP COVID-19 model.
Box-Behnken result Dead people Recovered people
Value P-val Value P-val
(Intercept) 186,753.3 <0.001 25,839,046.5 <0.001
Contagious period 60.8 0.68 −63,596.1 <0.001
Number of foci 164.5 0.28 −2100.5 0.70
Probability of transmission 57,799 <0.001 8,004,546.4 <0.001
Contagious period: number of foci 14.5 0.94 −1785.5 0.81
Contagious period: probability of
transmission
242 0.27 11,082.8 0.18
Number of foci: probability of
transmission
73.5 0.72 −720.5 0.92
Contagious period2 63.6 0.76 −8292.9 0.30
Number of foci2 −129.9 0.54 6126.9 0.43
Probability of transmission2 −14,053.4 <0.001 −1,984,689.4 <0.001
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The sensitivity of the model was assessed using a Box-Behnken de-
sign. Variations in the outcome of the model were studied depending
on the number of foci, the probability of transmission of the disease,
and the duration of the contagious period. The two response surfaces
are detailed in Table 4.
The two outcome variables (dead and recovered people) were sig-
nificantly sensitive to variations in the probability of transmission of
the disease (p < 0.05). Thus, a 1% increase in the probability ofFig. 3.A)Number of deaths depending on theprobability of transmission used formodelling and
(Rt) calculated from the data obtained from themodel, in the case of a 10% probability of transm
Spanish Department of Health (from 25 February 2020 to 24May 2020, a 90-day series) using th
line: model data; red line: official data. (For interpretation of the references to colour in this fi
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transmission resulted in a 0.03% increase (11,560 people) and 3.48% in-
crease (1,600,909 people) in the number of people who died and recov-
ered in the Spanish population, respectively (Table 5). However, the
only outcome variable that was significantly sensitive to variations in
the contagious period was the number of people who recovered, but
the effect of changing this variable by 1% was less than the effect duethe official data from the SpanishDepartment ofHealth. B) Effective reproduction number
ission of the disease from infected to non-infected people, and thefigures published by the
e EpiEstim package as described in Cori et al. (2013) andWallinga and Teunis (2004). Blue
gure legend, the reader is referred to the web version of this article.)
Table 5
Effect of an increase of 1% in the independent variables on the outcome of the model.
Sensitivity Dead people Recovered people
Absolute Relativea Absolute Relativea
Number of foci 23.5 0.00% −300.07 0.00%
Probability of transmission 11,559.8 0.03% 1,600,909.28 3.48%
Contagious period 15.2 0.00% −15,899.025 −0.03%
a The relative value was calculated with respect to the total population, 46,014,554.
Table 6
GLMmodel results to study the effects of contact reduction measures, closure of commu-











Coefficient −4.81 238.88 287,909.44
P value 0.531 0.123 <0.001
Recovered people
D2 = 98.9
Coefficient −6454 −136,221 46,214,699
P value 0.431 0.406 <0.001
Table 7
Percentage of individuals with respect to the total population (46,014,554 people) as a
function of the % of the vaccinated population, and the probability of disease transmission
with and without social measures.
Probability of disease
transmission (%)




0 25 50 75 0 25 50 75
Recovered (%) 34.09 25.54 12.06 7.95 56.08 41.69 27.68 13.18
Dead (%) 0.25 0.15 0.08 0.06 0.41 0.25 0.14 0.10
M.ªÀ. Colomer, A. Margalida, F. Alòs et al. Science of the Total Environment 789 (2021) 147816to the probability of transmission (Table 5). Finally, the two outcome
variables were not significantly affected by variations in the number of
foci at the beginning of the outbreak (p > 0.05).Fig. 4. Graphs A and B show the progress of the death toll depending on the percentage of the
application of protective measures, respectively. Graphs C and D show the number of people
(from 0% (V0) to 75% (V75)), without and with the application of protective measures, respec
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3.2. Phase 2
3.2.1. Contact reduction, the closure of communities and protective measures
In Phase two, the effect of contact reduction measures, closure of
communities (lockdown) and protective measures (including face
mask wearing, social distancing and hand hygiene) were studied as
pandemic control measures, as detailed in the Materials and methods
section. Protectivemeasures significantly affected the two outcomevar-
iables in the long term (Table 6). The closure of communities and con-
tact reduction measures did not significantly affect the response
variables in the long term. It was not observed any significant interac-
tion (p > 0.05) in the GLM.
3.2.2. Trend of SARS-CoV-2 outbreak with vaccination and the application
of protective measures in the population
The effects of vaccinating 25, 50 and 75% of the population, both
without or with the application of additional control measures
were modelled (Table 7; Fig. 4). We also modelled the number of
people who died and recovered when the probability of transmission
was set to 0.1 (Phase 1 of this study) both without the application of
protective measures andwith thesemeasures in place (probability of
transmission of 0.05). In general terms, the best results (higher per-
centage of reduction in all the outcome variables) were observed
when the vaccine was administered to a larger part of the population
(75%), both without andwith the application of protective measures.
With this level of vaccine protection, the effect of protective mea-
sures on the final outcome of the pandemic was the least. However,
the results of the outcome variables were clearly improved by pro-
tective measures at the intermediate level (50%) of population vacci-
nation. Moreover, the largest reduction in the percentage of people
who died and recovered was observed when 25 and 50% of the pop-
ulation was vaccinated in combination with the application of pro-
tective measures versus vaccination without the application of
protective measures (Table 7; Fig. 4). It was not observed any signif-
icant interaction (p > 0.05) in the GLM.population protected by vaccination (from 0% (V0) to 75% (V75)), without and with the
who recovered depending on the percentage of the population protected by vaccination
tively.
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The recent recurrent global pandemic events in which virus dissem-
ination is not easily controlled have provoked social alarm among health
administrations resulting in significant social and economic impacts
(Yue et al., 2021). Epidemiological modelling is the most commonly
used means of providing data to help policy-makers anticipate and de-
sign the best management strategies to control any outbreak. However,
the difficulties of predicting the course of a pandemic like the current
one operate at three levels: the quality of the data; the suitability of
the epidemiological models; and the intrinsic uncertainty of the epide-
miological models (Yue et al., 2021; Poletto et al., 2020). At the begin-
ning of this pandemic, many epidemiological models were used, such
as SIR and its variants (SEIR, SITR, SIRS, SEQJR), that are based on differ-
ential equations (IHMECOVID-19 Forecasting Team;Al-Anzi et al., 2020;
Barbarossa et al., 2020; Goscé et al., 2020). These models have their
limitations in addressing complex problems for a new disease where
some of the key parameters are unknown and are difficult to apply to
a population where urgent measures are required to control the out-
break. Therefore, the control measures that they recommend require
modifying the basic epidemiological parameters for any disease (IHME
COVID-19 Forecasting Team; Goscé et al., 2020; Adiga et al., 2020;
Ortega et al., 2020; Tang and Wang, 2020). As a consequence, there
are many epidemiological models for COVID-19 in the literature with a
variety of conflicting predictions. Therefore, the Center for Disease
Control present these individual predictions for each model alongside
an “average” prediction taking account of all the models together
(https://www.cdc.gov/coronavirus/2019-ncov/covid-data/forecasting-
us.html).
In this paper, we propose a new computational model for COVID-19
(the PDP COVID-19model). This kind ofmodel has not higher computa-
tional costs but allows the study of complex problems in parallel, with
many interactions between them at individual level. PDPs are relatively
newmodels which have been successfully applied to the study of com-
plex ecosystems (Colomer et al., 2014) and for veterinary diseases
(Colomer et al., 2019, 2020). They allow the generation of a daily photo-
graph of all the individuals in the population, so it is possible to estimate
the number of people who are infected whether symptomatic, asymp-
tomatic, hospitalized, incubating the disease, or transmitting the disease
to other communities/people. Someof these outputs allow evaluation of
the dynamics of the pandemic while others can be used to estimate the
healthcare and financial resources that will be needed. The PDP model
uses epidemiological data for the disease (Table 1) but is flexible
enough to determine the basic reproduction ratio (Ro), the critical pa-
rameter for understanding the transmission of a disease at the popula-
tion level. Ro is an input parameter in many previously published
COVID-19 models (Liu et al., 2020a, 2020b; Yue et al., 2020). However,
in our model Ro does not need to be obtained from the literature to
set up the PDP model. It can be obtained as an outcome from the
model after setting different probabilities of transmission and checking
themodel prediction against actual infection data. This characteristic of
the model allows the Ro to be constantly checked as the outcomes of
various control measures are applied, something not possible with
other models [37–40]. Moreover, the sensitivity of the model can be
assessed using a Box-Behnken design. Variations in the outcome of the
model were studied depending on the number of initial foci, the proba-
bility of transmission of the disease, and the duration of the contagious
period. The sensitivity of the model was demonstrated for changes in
the probability of transmission of the disease, contagious period, and
the resulting numbers of people who died or recovered. In this way,
themodel can beused to analyse the relative efficacy of different control
measures. Finally, because PDP models are modular, they allow the in-
corporation of new components as new knowledge accumulates, espe-
cially important in the case of SARS-CoV-2 as the pandemic parameters
change and unfold. However, our PDP model has also limitations. Thus,
it was not considered potential changes to the virus transmissibility due9
to environmental factors such as temperature and humidity. Moreover,
the transmission among members of the same family is partially cap-
tured in themodel but it was not explicitly taking into account the effect
of transmission inside the family. Finally, our model did not also con-
sider the effect of different population density inside the communities
(Wongand Li, 2020) nor the reintroduction of SARS-CoV-2 into the pop-
ulation by infected travellers from other countries. In connection with
the control measures, themodel assumes that the vaccination is applied
randomly in the population without taking into account age groups.
However, governments are focusing the vaccination in high-risk groups
to decrease the hospitalizations and lethality in the population. Thus,
the output of our model can be considered a worst-case scenario in re-
lation with the outcome due to vaccination. Accordingly, our model is
probably underestimating the positive effects of the vaccination at pop-
ulation level comparedwith an age-driven vaccination approach.While
our results probably do not agree exactly with reality due to the former
reasons, they do serve as useful comparisons of the likely outcomes in
the presence of various controlmeasures. For this reason,we performed
extensive sensitivity analyses which show that the modelling results
presented here are robust within the plausible range of parameter
values for the course of the COVID-19 pandemic in Spain. In conclusion,
the differences described from the different interventions in the model
are quite robust in relative terms but the absolute values must be
interpretedwith caution because they are depending on the parameters
used to run this model plus the intrinsic limitations that any model has
to mimic reality.
Model validation was performed taking into account the official
Spanish death toll figures as themost robust key parameter. A probabil-
ity of transmission of 0.10 allows the prediction of data very close to the
real figures observed during the outbreak (Fig. 3) and was set as our
baseline level for the course of the pandemic without control measures.
Moreover, the Ro obtained from the model was also very close to the
data published by the Spanish Department of Health (Fig. 3). These re-
sults allowed us to confirm that the model was good enough to predict
the COVID-19 pandemic, at least in Spain. Our model must be checked
against the data from other countries if it is to be used worldwide. In
any case, our experience with the model in comparing different inter-
ventions to control the disease leads us to believe that the results can
be extrapolated to any other country.
The number of initial outbreaks and the contagious period are not
significant factors in determining the course of the COVID-19 pandemic,
probably due to the exponential spread of the disease (Sanche et al.,
2020). It is clear that lockdown and contact reduction measures are ef-
fective in controlling the COVID-19 pandemic in the short term (Kissler
et al., 2020). They have been widely applied in many countries as front-
line measures to avoid the collapse of national health systems but our
model foresees that these measures are not effective in controlling the
COVID-19 pandemic over the longer term because the initial course of
the disease has continued after the measures were lifted (Davies et al.,
2021; Li et al., 2021). However, our study concludes that reducing the
probability of transmission of the disease is a useful measure that does
reduce its spread over the long term. Unfortunately, measures such as
social distancing, hand hygiene and wearing face masks are difficult
for populations to accept over the long-term. Moreover, they are only
efficacious when population compliance is very high, and compliance
can be very variable across countries.
In this paper, we studied the effect of combining vaccination with
the application of protective measures to control the course of the
COVID-19 pandemic. It seems unnecessary to check the combination
of bothmeasures because of the high percentage reduction in the num-
ber of people who die or recover after infectionwhen a large proportion
of the population (75%) is protected with the vaccine, both without and
with the application of protective measures. Therefore, if this level of
vaccine protection could be achieved, the extra effect of protectivemea-
sures on the final outcome of the pandemic would be minimal.
However, the actual efficacy of the various COVID-19 vaccines is
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panies seems extraordinary (>90%) (Polack et al., 2020; Knoll and
Wonodi, 2020). In any case, the availability of the vaccine will be very
low atfirst, although supplies should increase during 2021. Itwill there-
fore be necessary to combine protective measures and vaccination for a
long time until high vaccination levels can be achieved. The results of
the outcome variables are clearly improved by protective measures at
intermediate population vaccination levels (25–50%). Therefore, the
largest variation in the percentage of people who die and recover was
observed when 25–50% of the population was protected by vaccination
in combinationwith protectivemeasures comparedwith 25–50% vacci-
nation and no protective measures. Finally, the effect of cost-effective
plan for global testing has not been addressed in this work but we
have also analyzed this control measure in a recent paper (Colomer
et al., 2021) where results clearly support the value of contact tracing
as an effective tool in controlling the course of the pandemic, in
common with other published studies (Aleta et al., 2020; Li and
Giabbanelli, 2020) even with a low (40%), but realistic level of contact
tracing. The problem with this measure is that it requires a large num-
ber of tests with a high cost for governments.
In summary, lockdowns and contact reduction measures only delay
the spread of the SARS-CoV-2 virus in the population because it resumes
its previous dynamics as soon as the restrictions are lifted. Accordingly,
the best approach would be to combine protective measures and vacci-
nation to reduce both the number of people who die and recover after
infection.
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